Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Research — Salary and employee benefits by Quarter
Research — Salary and employee benefits ($M) ($M)
Vertex Pharmaceuticals Research — Salary and employee benefits: $51.3M in Q2 2026, down 3.4% from a year earlier.
Where the Q2 2026 figure comes from
“|| Salary and benefits | $ 51.3 | $ 53.1 | (3)% | $ 106.5 | $ 106.2 | —%”
Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K MD&A (Research Expenses Disaggregation Table).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Research — Salary and employee benefits ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-res-salary
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.